Morin: A promising hepatoprotective agent against drug and chemical-induced liver injury
Potential Side Effects Reduces the production of new fat Boosts the number of calories burned Increases metabolism and promotes cartilage and bone healing Controls blood sugar Effectiveness of AOD 9604 According to a study on the metabolic effects of AOD 9604 in obese Zucker rats, the therapy significantly reduced body weight increase in comparison to the control group by more than 50%
GLP-1 medications can contribute to dehydration indirectly if nausea, vomiting, diarrhea, constipation, or reduced appetite lowers fluid intake
These are more likely to occur when you first start the medication or when you increase the dose
doi: 10.1016/S0140-6736(20)32511-3 Summary Keywords chronic liver disorder, metabolic syndrome, non-alcoholic fatty liver disease, oxidative stress, oral glutathione Citation Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV and Di Sabatino A (2023) Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease